biology

RAS-associated autoimmune leukoproliferative disorder

RAS-associated autoimmune leukoproliferative disorder is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand RAS-associated autoimmune leukoproliferative disorder rather than just read about it. In short: RAS-associated autoimmune leukoproliferative disorder (RALD) is a rare genetic disorder of the immune system. RALD is characterized by lymphadenopathy, splenomegaly, autoimmunity, and elevation in granulocytes and monocytes.

Key takeaways

RAS-associated autoimmune leukoproliferative disorder belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect RAS-associated autoimmune leukoproliferative disorder to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of RAS-associated autoimmune leukoproliferative disorder from memory before moving on to harder problems.

Reference excerpt

RAS-associated autoimmune leukoproliferative disorder (RALD) is a rare genetic disorder of the immune system. RALD is characterized by lymphadenopathy, splenomegaly, autoimmunity, and elevation in granulocytes and monocytes. It shares many features with autoimmune lymphoproliferative syndrome and is caused by somatic mutations in NRAS or KRAS. This was first described by investigators João Oliveira and Michael Lenardo from the National Institutes of Health.

Presentation Clinically, RALD is characterized by splenomegaly, a relatively mild degree of peripheral lymphadenopathy, and autoimmunity. The autoimmune phenotype can present in childhood or adulthood and primarily includes autoimmune hemolytic anemia, ITP, and neutropenia. Some patients have a history of recurrent respiratory tract infections. It is unclear if increased risk for malignancy is part of RALD. Importantly, however, the clinical and laboratory phenotype resembles juvenile myelomonocytic leukemia. The high fatality rate of this childhood blood cancer puts it in sharp contrast when compared to the relatively benign and chronic course of RALD. Approximately 15-30% of patients diagnosed with JMML have somatic, activating RAS mutations. However, due to the difficulty in distinguishing JMML from RALD, it is possible a subset of patients treated for JMML actually have RALD and could therefore avoid the aggressive JMML treatment. This distinction is under investigation.

Genetics RALD is caused by gain-of-function somatic mutations in the genes NRAS or KRAS. NRAS and KRAS are members of the RAS subfamily and are implicated in many types of cancer. Somatic mutations are changes in DNA that occur after conception. Although generally somatic mutations can develop in any cell of the body, in RALD the somatic mutations only reside in the blood cells. Because these mutations are acquired and not in the germline, they cannot be inherited or passed on to children.

Function Somatic RAS mutations greatly diminish the GTPase activity within the cell. The reduced GTPase activity locks the cells in an activated state and degrades the pro-apoptotic BIM protein, thus making the cells resistant to apoptosis. In contrast to ALPS, this apoptosis defect does not involve the FAS pathway.

Diagnosis RALD patients show normal to modestly decreased total lymphocytes, mild to no elevation in αβ-double negative T cells, a relative expansion of B cells, and elevated granulocytes and monocytes. The absolute or relative monocytosis in particular is an important characteristic of this disorder and help differentiate it from ALPS. Autoantibodies are also common.

Research Investigators at the National Institute of Allergy and Infectious Diseases at the US National Institutes of Health currently have clinical protocols to study new approaches to the diagnosis and treatment of this disorder.

References

External links

Worked examples

Example 1 — a first encounter with RAS-associated autoimmune leukoproliferative disorder

Start with the simplest possible case. Write down what RAS-associated autoimmune leukoproliferative disorder claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to RAS-associated autoimmune leukoproliferative disorder before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about RAS-associated autoimmune leukoproliferative disorder ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of RAS-associated autoimmune leukoproliferative disorder

In research: RAS-associated autoimmune leukoproliferative disorder appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses RAS-associated autoimmune leukoproliferative disorder in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: RAS-associated autoimmune leukoproliferative disorder is common in secondary-school and first-year university syllabi. It links to neighbouring topics Autoimmune diseases, Genetic diseases and disorders, Immune system disorders, so understanding it makes those chapters shorter.
In everyday life: Look for RAS-associated autoimmune leukoproliferative disorder outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “RAS-associated autoimmune leukoproliferative disorder” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study RAS-associated autoimmune leukoproliferative disorder in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what RAS-associated autoimmune leukoproliferative disorder means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain RAS-associated autoimmune leukoproliferative disorder out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is RAS-associated autoimmune leukoproliferative disorder in simple terms?

Why does RAS-associated autoimmune leukoproliferative disorder matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study RAS-associated autoimmune leukoproliferative disorder?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on RAS-associated autoimmune leukoproliferative disorder.